Harvard Apparatus Regenerative Technology, Inc. 8-K

What Happened
Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an 8-K reporting that on April 13, 2026 the company entered into a Bridge Note with Junli He, the Company’s Chairman and Chief Executive Officer. The Lender agreed to lend the company $300,000; the note accrues interest at a fixed 8% per year and is payable in full on the earlier of the closing of the company’s next capital raise that generates at least $5,000,000 in gross proceeds or April 13, 2027. The Bridge Note permits optional conversion at the Lender’s discretion and includes customary covenants and events of default.

Key Details

• Loan amount: $300,000, evidenced by a Bridge Note dated April 13, 2026.
• Interest: 8% fixed annual rate.
• Maturity: Due upon the earlier of (a) closing of a financing with ≥ $5,000,000 gross proceeds (or related later date tied to that offering) or (b) April 13, 2027.
• Other terms: Optional conversion at the Lender’s discretion; contains covenants and customary default provisions. Full note is filed as Exhibit 10.1.

Why It Matters
This transaction provides near-term liquidity from the company’s CEO, potentially helping operations while the company pursues a larger financing round. The loan’s maturity is tied to a sizable future capital raise (≥ $5M), so its repayment or conversion depends on HRGN completing that financing or repaying by April 13, 2027. Investors should note the insider source of funding (CEO) and the conversion feature, which could affect equity if exercised. The filing is informational; it does not disclose whether or when the larger $5M financing will occur.